Download PDF
Semin Neurol 2020; 40(06): 638-646
DOI: 10.1055/s-0040-1718720
Review Article

Epilepsy—Work-Up and Management in Children

Jeffrey R. Tenney 
1   Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio
2   Division of Neurology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio
› Author Affiliations
› Further Information
    Permissions and Reprints

Abstract

Pediatric epilepsy is a highly variable condition due to age-related expression of syndromes that require specific diagnosis, evaluations, and treatments. Children with epilepsy differ from their adult counterparts in many important ways, mostly related to the age-related expression of specific epilepsy syndromes. This results in many important considerations related to the epilepsy diagnosis, classification, evaluations to determine an etiology, as well as treatment guidelines. A good understanding of these factors will help to establish an accurate epilepsy diagnosis, which in turn will guide appropriate testing and treatment decisions. In this way, patients will have improved seizure outcomes, and families will be educated appropriately and provided with the most accurate prognostic information available. The purpose of this article is to review the diagnosis, work-up, and management of pediatric epilepsy.

Keywords

epilepsy - pediatrics - management - work-up


Publication History

Article published online:
11 November 2020

© 2020. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Fisher RS, van Emde Boas W, Blume W. et al. Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE). Epilepsia 2005; 46 (04) 470-472
    CrossrefPubMedSearch in Google Scholar
  • 2 Villanueva V, Sánchez-Álvarez JC, Peña P, Puig JS, Caballero-Martínez F, Gil-Nagel A. Treatment initiation in epilepsy: an expert consensus in Spain. Epilepsy Behav 2010; 19 (03) 332-342
    CrossrefPubMedSearch in Google Scholar
  • 3 Hauser WA, Annegers JF, Kurland LT. Prevalence of epilepsy in Rochester, Minnesota: 1940-1980. Epilepsia 1991; 32 (04) 429-445
    CrossrefPubMedSearch in Google Scholar
  • 4 Fisher RS, Acevedo C, Arzimanoglou A. et al. ILAE official report: a practical clinical definition of epilepsy. Epilepsia 2014; 55 (04) 475-482
    Search in Google Scholar
  • 5 Kim LG, Johnson TL, Marson AG, Chadwick DW. MRC MESS Study group. Prediction of risk of seizure recurrence after a single seizure and early epilepsy: further results from the MESS trial. Lancet Neurol 2006; 5 (04) 317-322
    CrossrefPubMedSearch in Google Scholar
  • 6 Stroink H, Brouwer OF, Arts WF, Geerts AT, Peters AC, van Donselaar CA. The first unprovoked, untreated seizure in childhood: a hospital based study of the accuracy of the diagnosis, rate of recurrence, and long term outcome after recurrence. Dutch study of epilepsy in childhood. J Neurol Neurosurg Psychiatry 1998; 64 (05) 595-600
    CrossrefPubMedSearch in Google Scholar
  • 7 Shinnar S, Berg AT, Moshé SL. et al. Risk of seizure recurrence following a first unprovoked seizure in childhood: a prospective study. Pediatrics 1990; 85 (06) 1076-1085
    CrossrefPubMedSearch in Google Scholar
  • 8 Berg AT, Berkovic SF, Brodie MJ. et al. Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005-2009. Epilepsia 2010; 51 (04) 676-685
    Search in Google Scholar
  • 9 Sinclair DB, Snyder TJ. Corticosteroids for the treatment of Landau-kleffner syndrome and continuous spike-wave discharge during sleep. Pediatr Neurol 2005; 32 (05) 300-306
    CrossrefPubMedSearch in Google Scholar
  • 10 Hauptman JS, Salamon N, Mathern GW. Neuroimaging in the definition and organization of the epilepsies: we're not there yet. Epilepsia 2012; 53 (Suppl. 02) 22-27
    CrossrefPubMedSearch in Google Scholar
  • 11 Scheffer IE, Berkovic S, Capovilla G. et al. ILAE classification of the epilepsies: position paper of the ILAE Commission for Classification and Terminology. Epilepsia 2017; 58 (04) 512-521
    Search in Google Scholar
  • 12 Blümcke I, Thom M, Aronica E. et al. The clinicopathologic spectrum of focal cortical dysplasias: a consensus classification proposed by an ad hoc task force of the ILAE Diagnostic Methods Commission. Epilepsia 2011; 52 (01) 158-174
    CrossrefPubMedSearch in Google Scholar
  • 13 Linehan C, Tellez-Zenteno JF, Burneo JG, Berg AT. Future directions for epidemiology in epilepsy. Epilepsy Behav 2011; 22 (01) 112-117
    CrossrefPubMedSearch in Google Scholar
  • 14 Korff CM, Scheffer IE. Epilepsy classification: a cycle of evolution and revolution. Curr Opin Neurol 2013; 26 (02) 163-167
    CrossrefPubMedSearch in Google Scholar
  • 15 Tirosh E, Jaffe M, Dar H. The clinical significance of multiple hair whorls and their association with unusual dermatoglyphics and dysmorphic features in mentally retarded Israeli children. Eur J Pediatr 1987; 146 (06) 568-570
    CrossrefPubMedSearch in Google Scholar
  • 16 Fountain NB, Freeman JM. EEG is an essential clinical tool: pro and con. Epilepsia 2006; 47 (Suppl. 01) 23-25
    CrossrefPubMedSearch in Google Scholar
  • 17 Sansevere AJ, Avalone J, Strauss LD. et al. Diagnostic and therapeutic management of a first unprovoked seizure in children and adolescents with a focus on the revised diagnostic criteria for epilepsy. J Child Neurol 2017; 32 (08) 774-788
    CrossrefPubMedSearch in Google Scholar
  • 18 Binnie CD, Rowan AJ, Overweg J. et al. Telemetric EEG and video monitoring in epilepsy. Neurology 1981; 31 (03) 298-303
    CrossrefPubMedSearch in Google Scholar
  • 19 Theitler J, Dassa D, Gandelman-Marton R. The yield of non-elective inpatient video-EEG monitoring in adults. Neurol Sci 2017; 38 (06) 961-965
    CrossrefPubMedSearch in Google Scholar
  • 20 Bennett-Back O, Uliel-Siboni S, Kramer U. The yield of video-EEG telemetry evaluation for non-surgical candidate children. Eur J Paediatr Neurol 2016; 20 (06) 848-854
    CrossrefPubMedSearch in Google Scholar
  • 21 Lawley A, Evans S, Manfredonia F, Cavanna AE. The role of outpatient ambulatory electroencephalography in the diagnosis and management of adults with epilepsy or nonepileptic attack disorder: a systematic literature review. Epilepsy Behav 2015; 53: 26-30
    CrossrefPubMedSearch in Google Scholar
  • 22 Dash D, Hernandez-Ronquillo L, Moien-Afshari F, Tellez-Zenteno JF. Ambulatory EEG: a cost-effective alternative to inpatient video-EEG in adult patients. Epileptic Disord 2012; 14 (03) 290-297
    CrossrefPubMedSearch in Google Scholar
  • 23 Kandler R, Ponnusamy A, Wragg C. Video ambulatory EEG: a good alternative to inpatient video telemetry?. Seizure 2017; 47: 66-70
    CrossrefPubMedSearch in Google Scholar
  • 24 Goodwin E, Kandler RH, Alix JJ. The value of home video with ambulatory EEG: a prospective service review. Seizure 2014; 23 (06) 480-482
    CrossrefPubMedSearch in Google Scholar
  • 25 Syed TU, LaFrance Jr WC, Loddenkemper T. et al. Outcome of ambulatory video-EEG monitoring in a ã 10,000 patient nationwide cohort. Seizure 2019; 66: 104-111
    CrossrefPubMedSearch in Google Scholar
  • 26 Pittau F, Grouiller F, Spinelli L, Seeck M, Michel CM, Vulliemoz S. The role of functional neuroimaging in pre-surgical epilepsy evaluation. Front Neurol 2014; 5: 31
    CrossrefPubMedSearch in Google Scholar
  • 27 Zubler F, Seeck M, Landis T, Henry F, Lazeyras F. Contralateral medial temporal lobe damage in right but not left temporal lobe epilepsy: a (1)H magnetic resonance spectroscopy study. J Neurol Neurosurg Psychiatry 2003; 74 (09) 1240-1244
    CrossrefPubMedSearch in Google Scholar
  • 28 deGrauw TJ, Salomons GS, Cecil KM. et al. Congenital creatine transporter deficiency. Neuropediatrics 2002; 33 (05) 232-238
    Thieme ConnectPubMedSearch in Google Scholar
  • 29 Filippi CG, Uluğ AM, Deck MD, Zimmerman RD, Heier LA. Developmental delay in children: assessment with proton MR spectroscopy. AJNR Am J Neuroradiol 2002; 23 (05) 882-888
    PubMedSearch in Google Scholar
  • 30 Grodd W, Krägeloh-Mann I, Klose U, Sauter R. Metabolic and destructive brain disorders in children: findings with localized proton MR spectroscopy. Radiology 1991; 181 (01) 173-181
    CrossrefPubMedSearch in Google Scholar
  • 31 Tzika AA, Vajapeyam S, Barnes PD. Multivoxel proton MR spectroscopy and hemodynamic MR imaging of childhood brain tumors: preliminary observations. AJNR Am J Neuroradiol 1997; 18 (02) 203-218
    PubMedSearch in Google Scholar
  • 32 Ream MA, Mikati MA. Clinical utility of genetic testing in pediatric drug-resistant epilepsy: a pilot study. Epilepsy Behav 2014; 37: 241-248
    CrossrefPubMedSearch in Google Scholar
  • 33 Sands TT, Choi H. Genetic testing in pediatric epilepsy. Curr Neurol Neurosci Rep 2017; 17 (05) 45
    CrossrefPubMedSearch in Google Scholar
  • 34 Ream MA, Patel AD. Obtaining genetic testing in pediatric epilepsy. Epilepsia 2015; 56 (10) 1505-1514
    CrossrefPubMedSearch in Google Scholar
  • 35 Lemke JR, Riesch E, Scheurenbrand T. et al. Targeted next generation sequencing as a diagnostic tool in epileptic disorders. Epilepsia 2012; 53 (08) 1387-1398
    CrossrefPubMedSearch in Google Scholar
  • 36 Soden SE, Saunders CJ, Willig LK. et al. Effectiveness of exome and genome sequencing guided by acuity of illness for diagnosis of neurodevelopmental disorders. Sci Transl Med 2014; 6 (265) 265ra168
    Search in Google Scholar
  • 37 Dixon-Salazar TJ, Silhavy JL, Udpa N. et al. Exome sequencing can improve diagnosis and alter patient management. Sci Transl Med 2012; 4 (138) 138ra78
    PubMedSearch in Google Scholar
  • 38 Sankar R. Initial treatment of epilepsy with antiepileptic drugs: pediatric issues. Neurology 2004; 63 (10) (Suppl. 04) S30-S39
    CrossrefPubMedSearch in Google Scholar
  • 39 Reynolds EH, Shorvon SD. Monotherapy or polytherapy for epilepsy?. Epilepsia 1981; 22 (01) 1-10
    CrossrefPubMedSearch in Google Scholar
  • 40 Chadwick DW. Overuse of monitoring of blood concentrations of antiepileptic drugs. Br Med J (Clin Res Ed) 1987; 294 (6574): 723-724
    CrossrefPubMedSearch in Google Scholar
  • 41 Pellock JM, Willmore LJ. A rational guide to routine blood monitoring in patients receiving antiepileptic drugs. Neurology 1991; 41 (07) 961-964
    CrossrefPubMedSearch in Google Scholar
  • 42 Lamberink HJ, Otte WM, Geerts AT. et al. Individualised prediction model of seizure recurrence and long-term outcomes after withdrawal of antiepileptic drugs in seizure-free patients: a systematic review and individual participant data meta-analysis. Lancet Neurol 2017; 16 (07) 523-531
    CrossrefPubMedSearch in Google Scholar
  • 43 Kwan P, Arzimanoglou A, Berg AT. et al. Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia 2010; 51 (06) 1069-1077
    Search in Google Scholar
  • 44 Burneo JG, Shariff SZ, Liu K, Leonard S, Saposnik G, Garg AX. Disparities in surgery among patients with intractable epilepsy in a universal health system. Neurology 2016; 86 (01) 72-78
    CrossrefPubMedSearch in Google Scholar
  • 45 Reilly C, Atkinson P, Das KB. et al. Neurobehavioral comorbidities in children with active epilepsy: a population-based study. Pediatrics 2014; 133 (06) e1586-e1593
    CrossrefPubMedSearch in Google Scholar
  • 46 Russ SA, Larson K, Halfon N. A national profile of childhood epilepsy and seizure disorder. Pediatrics 2012; 129 (02) 256-264
    CrossrefPubMedSearch in Google Scholar
  • 47 Guilfoyle SM, Follansbee-Junger K, Smith AW. et al. Antiepileptic drug behavioral side effects and baseline hyperactivity in children and adolescents with new onset epilepsy. Epilepsia 2018; 59 (01) 146-154
    CrossrefPubMedSearch in Google Scholar
  • 48 Austin JK, Harezlak J, Dunn DW, Huster GA, Rose DF, Ambrosius WT. Behavior problems in children before first recognized seizures. Pediatrics 2001; 107 (01) 115-122
    CrossrefPubMedSearch in Google Scholar
  • 49 Kanner AM. Psychiatric comorbidities in new onset epilepsy: should they be always investigated?. Seizure 2017; 49: 79-82
    CrossrefPubMedSearch in Google Scholar
  • 50 Barry JJ, Ettinger AB, Friel P. Advisory Group of the Epilepsy Foundation as part of its Mood Disorder. et al. Consensus statement: the evaluation and treatment of people with epilepsy and affective disorders. Epilepsy Behav 2008; 13 (Suppl. 01) S1-S29
    CrossrefPubMedSearch in Google Scholar
  • 51 Fountain NB, Van Ness PC, Bennett A. et al. Quality improvement in neurology: epilepsy update quality measurement set. Neurology 2015; 84 (14) 1483-1487
    CrossrefPubMedSearch in Google Scholar
  • 52 Kerr MP, Mensah S, Besag F. International League of Epilepsy (ILAE) Commission on the Neuropsychiatric Aspects of Epilepsy. et al. International consensus clinical practice statements for the treatment of neuropsychiatric conditions associated with epilepsy. Epilepsia 2011; 52 (11) 2133-2138
    CrossrefPubMedSearch in Google Scholar
  • 53 Wilson SJ, Baxendale S, Barr W. et al. Indications and expectations for neuropsychological assessment in routine epilepsy care: report of the ILAE Neuropsychology Task Force, Diagnostic Methods Commission, 2013-2017. Epilepsia 2015; 56 (05) 674-681
    CrossrefPubMedSearch in Google Scholar
  • 54 Wagner JL, Modi AC, Guilfoyle SM. et al. Current behavioral health and cognitive screening practices in pediatric epilepsy. Epilepsy Behav 2019; 101 (Pt A): 106214
    CrossrefPubMedSearch in Google Scholar
  • 55 Guilfoyle SM, Monahan S, Wesolowski C, Modi AC. Depression screening in pediatric epilepsy: evidence for the benefit of a behavioral medicine service in early detection. Epilepsy Behav 2015; 44: 5-10
    CrossrefPubMedSearch in Google Scholar
  • 56 Wagner JL, Guilfoyle SM, Rausch J, Modi AC. Psychometric validation of the Pediatric Symptom Checklist-17 in a pediatric population with epilepsy: a methods study. Epilepsy Behav 2015; 51: 112-116
    CrossrefPubMedSearch in Google Scholar
  • 57 Helmers SL, Kobau R, Sajatovic M. Centers for Disease Control and Prevention Managing Epilepsy Well Network. et al. Self-management in epilepsy: why and how you should incorporate self-management in your practice. Epilepsy Behav 2017; 68: 220-224
    CrossrefPubMedSearch in Google Scholar
  • 58 Nashef L. Sudden unexpected death in epilepsy: terminology and definitions. Epilepsia 1997; 38 (11) S6-S8
    CrossrefPubMedSearch in Google Scholar
  • 59 Devinsky O. Sudden, unexpected death in epilepsy. N Engl J Med 2011; 365 (19) 1801-1811
    CrossrefPubMedSearch in Google Scholar
  • 60 Annegers JF. United States perspective on definitions and classifications. Epilepsia 1997; 38 (11) S9-S12
    CrossrefPubMedSearch in Google Scholar
  • 61 Harden C, Tomson T, Gloss D. et al. Practice guideline summary: sudden unexpected death in epilepsy incidence rates and risk factors: report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology 2017; 88 (17) 1674-1680
    CrossrefPubMedSearch in Google Scholar
  • 62 Ryvlin P, Nashef L, Lhatoo SD. et al. Incidence and mechanisms of cardiorespiratory arrests in epilepsy monitoring units (MORTEMUS): a retrospective study. Lancet Neurol 2013; 12 (10) 966-977
    CrossrefPubMedSearch in Google Scholar
  • 63 Harden C, Tomson T, Gloss D. et al. Practice guideline summary: sudden unexpected death in epilepsy incidence rates and risk factors: report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Epilepsy Curr 2017; 17 (03) 180-187
    CrossrefPubMedSearch in Google Scholar
  • 64 Xu Z, Ayyappan S, Seneviratne U. Sudden unexpected death in epilepsy (SUDEP): what do patients think?. Epilepsy Behav 2015; 42: 29-34
    CrossrefPubMedSearch in Google Scholar
  • 65 Morton B, Richardson A, Duncan S. Sudden unexpected death in epilepsy (SUDEP): don't ask, don't tell?. J Neurol Neurosurg Psychiatry 2006; 77 (02) 199-202
    CrossrefPubMedSearch in Google Scholar
  • 66 Cornet MC, Sands TT, Cilio MR. Neonatal epilepsies: clinical management. Semin Fetal Neonatal Med 2018; 23 (03) 204-212
    CrossrefPubMedSearch in Google Scholar
  • 67 Miceli F, Soldovieri MV, Ambrosino P. et al. Genotype-phenotype correlations in neonatal epilepsies caused by mutations in the voltage sensor of K(v)7.2 potassium channel subunits. Proc Natl Acad Sci U S A 2013; 110 (11) 4386-4391
    CrossrefPubMedSearch in Google Scholar
  • 68 Shellhaas RA, Wusthoff CJ, Tsuchida TN. Neonatal Seizure Registry. et al. Profile of neonatal epilepsies: characteristics of a prospective US cohort. Neurology 2017; 89 (09) 893-899
    CrossrefPubMedSearch in Google Scholar
  • 69 Numis AL, Angriman M, Sullivan JE. et al. KCNQ2 encephalopathy: delineation of the electroclinical phenotype and treatment response. Neurology 2014; 82 (04) 368-370
    CrossrefPubMedSearch in Google Scholar
  • 70 Bahi-Buisson N, Kaminska A, Boddaert N. et al. The three stages of epilepsy in patients with CDKL5 mutations. Epilepsia 2008; 49 (06) 1027-1037
    CrossrefPubMedSearch in Google Scholar
  • 71 Weeke LC, Brilstra E, Braun KP. et al. Punctate white matter lesions in full-term infants with neonatal seizures associated with SLC13A5 mutations. Eur J Paediatr Neurol 2017; 21 (02) 396-403
    CrossrefPubMedSearch in Google Scholar
  • 72 Barcia G, Fleming MR, Deligniere A. et al. De novo gain-of-function KCNT1 channel mutations cause malignant migrating partial seizures of infancy. Nat Genet 2012; 44 (11) 1255-1259
    CrossrefPubMedSearch in Google Scholar
  • 73 Stamberger H, Nikanorova M, Willemsen MH. et al. STXBP1 encephalopathy: a neurodevelopmental disorder including epilepsy. Neurology 2016; 86 (10) 954-962
    CrossrefPubMedSearch in Google Scholar
  • 74 Vilan A, Mendes Ribeiro J, Striano P. et al. A distinctive ictal amplitude-integrated electroencephalography pattern in newborns with neonatal epilepsy associated with KCNQ2 mutations. Neonatology 2017; 112 (04) 387-393
    CrossrefPubMedSearch in Google Scholar
  • 75 Bulteau C, Otsuki T, Delalande O. Epilepsy surgery for hemispheric syndromes in infants: hemimegalencepahly and hemispheric cortical dysplasia. Brain Dev 2013; 35 (08) 742-747
    CrossrefPubMedSearch in Google Scholar
  • 76 Chiron C, Dumas C, Jambaqué I, Mumford J, Dulac O. Randomized trial comparing vigabatrin and hydrocortisone in infantile spasms due to tuberous sclerosis. Epilepsy Res 1997; 26 (02) 389-395
    CrossrefPubMedSearch in Google Scholar
  • 77 Franz DN, Krueger DA. mTOR inhibitor therapy as a disease modifying therapy for tuberous sclerosis complex. Am J Med Genet C Semin Med Genet 2018; 178 (03) 365-373
    CrossrefPubMedSearch in Google Scholar
  • 78 Ficicioglu C, Bearden D. Isolated neonatal seizures: when to suspect inborn errors of metabolism. Pediatr Neurol 2011; 45 (05) 283-291
    CrossrefPubMedSearch in Google Scholar
  • 79 Hernan AE, Holmes GL. Antiepileptic drug treatment strategies in neonatal epilepsy. Prog Brain Res 2016; 226: 179-193
    CrossrefPubMedSearch in Google Scholar
  • 80 Painter MJ, Scher MS, Stein AD. et al. Phenobarbital compared with phenytoin for the treatment of neonatal seizures. N Engl J Med 1999; 341 (07) 485-489
    CrossrefPubMedSearch in Google Scholar
  • 81 Glauser TA, Cnaan A, Shinnar S. Childhood Absence Epilepsy Study Group. et al. Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy. N Engl J Med 2010; 362 (09) 790-799
    CrossrefPubMedSearch in Google Scholar
  • 82 Glauser TA, Cnaan A, Shinnar S. Childhood Absence Epilepsy Study Team. et al. Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy: initial monotherapy outcomes at 12 months. Epilepsia 2013; 54 (01) 141-155
    CrossrefPubMedSearch in Google Scholar
  • 83 Felbamate Study Group in Lennox-Gastaut Syndrome. Efficacy of felbamate in childhood epileptic encephalopathy (Lennox-Gastaut syndrome). N Engl J Med 1993; 328 (01) 29-33
    CrossrefPubMedSearch in Google Scholar
  • 84 Glauser T, Kluger G, Sachdeo R, Krauss G, Perdomo C, Arroyo S. Rufinamide for generalized seizures associated with Lennox-Gastaut syndrome. Neurology 2008; 70 (21) 1950-1958
    CrossrefPubMedSearch in Google Scholar
  • 85 Motte J, Trevathan E, Arvidsson JF, Barrera MN, Mullens EL, Manasco P. Lamictal Lennox-Gastaut Study Group. Lamotrigine for generalized seizures associated with the Lennox-Gastaut syndrome. N Engl J Med 1997; 337 (25) 1807-1812
    CrossrefPubMedSearch in Google Scholar
  • 86 Ng YT, Conry JA, Drummond R, Stolle J, Weinberg MA. OV-1012 Study Investigators. Randomized, phase III study results of clobazam in Lennox-Gastaut syndrome. Neurology 2011; 77 (15) 1473-1481
    CrossrefPubMedSearch in Google Scholar
  • 87 Sachdeo RC, Glauser TA, Ritter F, Reife R, Lim P, Pledger G. Topiramate YL Study Group. A double-blind, randomized trial of topiramate in Lennox-Gastaut syndrome. Neurology 1999; 52 (09) 1882-1887
    CrossrefPubMedSearch in Google Scholar
  • 88 Gastaut H. Benign epilepsy of childhood with occipital paroxysms. In: Roger J, Dravet CH, Bureau M, Dreiffus FE, Wolf P. eds. Epileptic Syndromes in Infancy, Childhood and Adolescence. London: John Libbey; 1985
    Search in Google Scholar